Las Vegas skyline [Adobe Stock]
While San Francisco, Boston, and San Diego may reign as biotech royalty, a new contender is carving its niche in the desert. Las Vegas, a city synonymous with entertainment and extravagance, is proving it has the brains and the business acumen to compete on the global biopharmaceutical stage. This transformation is backed by hard numbers: the Nevada bioscience sector boasts 9,413 jobs.The city is helping drive Nevada’s bioscience sector growth, which experienced a 22% growth surge from 2018 to 2021, far exceeding the national average. Its recent Super Bowl spotlight illuminated more than just football; it revealed a city where world-class researchers, visionary investors, and ambitious startups are fueling a bioscience boom.
Tina Quigley, president and CEO of the Las Vegas Global Economic Alliance (LGVEA), emphasized the strategic positioning of Las Vegas in the bi…